FEI establishment
PAREXEL Early Phase Clinical Unit
FDA establishment FEI 3005445577 · Baltimore, United States
Key facts
| FEI number | 3005445577 |
|---|---|
| Legal name | PAREXEL Early Phase Clinical Unit |
| City | Baltimore |
| Country | United States |
| Product types | Drugs |
| Last inspection | Oct 17, 2018 |
At a glance
- 1–9 FDA inspections
- 1–9 No Action Indicated (NAI)
- 1–9 Voluntary Action Indicated (VAI)
- None Official Action Indicated (OAI)
- 1–9 Inspections with a Form 483
- 1–9 Citations
- None Repeat citations
- None Warning letters
- None Linked 510(k)s
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA establishments (FEI)
An FEI (FDA Establishment Identifier) is the number the FDA assigns to a site it inspects. FEIs of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection and compliance data